We are drug discovery professionals.
We are industry specialists.
We are scientists.
We are drug discovery professionals.
We are industry specialists.
We are scientists.
All
Founders
Leadership
Team
Mike Acker
Biophysics & Biochemistry
Haley Amemiya
Computational Biology
Viral Amin
Chemical Biology
Dana Arndt
Senior Talent Acquisition Partner
Yonghong Bai
Structural Biology
Theresa Baker
Biology
Hans Bitter
Data Science
Kesler Bonheur
Lab & Facilities Operations
Giulia Bottoni
Biology
Erin Brophy
Biophysics & Biochemistry
Tom Carter
Administration
Kiley Couto
Biology
Hannah D’Amato
Human Resources
Manaswni Dhingra
Biochemistry & Biophysics
Allison Drew
Biology
Erica Evans
Biology
Kristina Fetalvero
Biology
Cen Gao
Computational Chemistry
Wenhua Gao
Biology
Andy Garner
Biology
Daniela Georgieva
Biology
Javad Golji
Computational Biology
Tim Guzi
SVP, Drug Discovery
Peter Hammerman
Chief Scientific Officer
Kate Hardy
Technology & Informatics
Maureen Hill
Biophysics & Biochemistry
Dorothee Kern
HHMI, Brandeis University
Jordan Krall
Biology
Elden Lainez
Lab & Facilities Operations
Jeansun Lee
Technology & Informatics
Chris Mahoney
Biology
Nazareth Martinez
Finance
Meredeth McGowan
Medicinal Chemistry
Kelly McGlynn
Biology
Doug McLaughlin
Chemical Biology
Brian McMillan
Biophysics & Biochemistry
Mike Miller
Finance
Vinny Motwani
Biology
Daniel Myung
Data Science
Eva Nogales
HHMI, UC Berkeley
Suzann OBrien
Administration
Asit Parikh
Chief Executive Officer
Jenna Persson
Biology
Matt Plant
Chemical Biology
Christopher Quinn
Biophysics & Biochemistry
Michael Reutershan
Medicinal Chemistry
Julia Ripple
TA & HR Ops Coordinator
Nathan Rockwell
Biology
Gabriela Rodriguez Vasquez
Lab & Facilities Operations
Max Russo
Biology
Laurie Schenkel
Medicinal Chemistry
Brian Sosa-Alvarado
Structural Biology
Semi Trotto
Chief People and Experience Officer
Anthony Tubbs
Biology
Cindy Yan
Computational Chemistry
Timur Yusufzai
Founder
James Villa
Research Strategy & Operations
Brian Villalba
Biophysics & Biochemistry
Johannes Walter
HHMI, Harvard Medical School
Haoxuan Wang
Medicinal Chemistry
Tina Yuan
Biology
BOARD OF DIRECTORS
Asit Parikh, M.D., Ph.D. — CEO, MOMA Therapeutics
Reid Huber, Ph.D. — Partner, Third Rock Ventures
Christoph Lengauer, Ph.D. — Partner, Third Rock Ventures
Thilo Schroeder, Ph.D — Partner, Nextech Invest
Amit Sinha — Managing Director, Goldman Sachs Asset Management
BOARD OBSERVERS
Bihua Chen — CEO, Cormorant Asset Management
Walt Kowtoniuk, Ph.D. — Venture Partner, Third Rock Ventures
Investors